Dark

CASI
CASI Pharmaceuticals, Inc.
stock NASDAQ

At Close

Dec 29, 2025 3:59:30 PM EST

0.7728USD-2.115%(-0.0167)45,692

0.00Bid 0.00Ask 0.0000Spread

Pre-market

0.00USD-100.000%(-0.79)0

After-hours

Dec 29, 2025 4:50:30 PM EST

0.7572USD-2.019%(-0.0156)250

OverviewOptionsHistoricalExchangesShortsNews

Jan 20, 2022

07:25AM EST CASI Pharmaceuticals Inc. (CASI) said that the U.S. Food and Drug Administration has granted Orphan Drug Designation to its partner BioInvent International AB, for BI-1206, an investigational anti-FcyRllB antibody, for the treatment of follicular lymphoma, the most common form of slow-growing Non-Hodgkin lymphoma or NHL. RTTNews

07:13AM EST CASI Pharmaceuticals Partner, BioInvent, Announces BI -1206 Has Been Granted Orphan Drug Designation By The U.S. FDA For The Treatment Of Patients With Follicular Lymphoma Benzinga

07:09AM EST Casi Partner, Bioinvent, Announces Bi-1206 Granted Orphan Drug Designation By FDA For Follicular Lymphoma Treatment RTTNews

07:01AM EST DESIGNATION BY THE U.S. FDA FOR THE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA PR Newswire

Jan 18, 2022

07:08AM EST Casi Pharmaceuticals Announces CNCT19 Granted Orphan Drug Designation By FDA Benzinga

07:05AM EST CASI Pharma Says US FDA Grants Orphan Drug Designation To Its Partner Juventas Cell Therapy For CNCT19 RTTNews

07:01AM EST CASI PHARMACEUTICALS ANNOUNCES CNCT19 (CD19 CAR-T) GRANTED ORPHAN DRUG PR Newswire

Jan 3, 2022

07:03AM EST CASI Pharma Received a Deficiency Letter from the Nasdaq Due to the Stock Price Being too Low Benzinga

07:02AM EST Casi Pharma Receives Nasdaq Deficiency Notice RTTNews

07:01AM EST CASI PHARMACEUTICALS, RECEIVES NASDAQ DEFICIENCY NOTICE PR Newswire

Dec 17, 2021

07:54AM EST The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx Benzinga

07:03AM EST CASI Pharma Reports $10M Buyback Benzinga

07:01AM EST CASI PHARMACEUTICALS ANNOUNCES STOCK REPURCHASE PROGRAM PR Newswire

Dec 10, 2021

07:03AM EST CASI Pharma, Bioinvent Report Approval Of Co.'s Clinical Trial Application For Study Of BI-1206 In Non-Hodgkins Lymphoma In China Benzinga

07:01AM EST CASI PHARMACEUTICALS AND BIOINVENT ANNOUNCE CTA APPROVAL FOR CLINICAL STUDY OF PR Newswire

Dec 6, 2021

06:07AM EST The Week Ahead In Biotech (Dec. 6-Dec. 11): Dar FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More Benzinga

Nov 19, 2021

04:40PM EST CASI Pharmaceuticals, Inc. Director, Chairman And CEO He Wei-Wu Buys 400,000 Shares At Avg Price: $0.98 Benzinga

Nov 15, 2021

07:01AM EST CASI Pharmaceuticals To Present At Jefferies London Healthcare Conference PR Newswire

Nov 12, 2021

07:47AM EST The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares Benzinga

07:31AM EST CASI Pharmaceuticals Q3 EPS $(0.07) Misses $(0.05) Estimate, Sales $8.11M Beat $7.54M Estimate Benzinga

07:04AM EST CASI Pharma Q3 Loss Per Share $0.07 Vs Loss $0.14 Last Year RTTNews

07:01AM EST CASI Pharmaceuticals Announces Third Quarter 2021 Financial Results PR Newswire

04:26AM EST Earnings Scheduled For November 12, 2021 Benzinga

Nov 11, 2021

10:03AM EST CASI Pharmaceuticals Earnings Preview Benzinga

Nov 5, 2021

09:39AM EDT CASI Pharma Reports Its Partner, BioInvent, To Present Further Clinical Data On BI-1206 At American Society Of Hematology Benzinga

07:01AM EDT CASI Pharmaceuticals Partner, BioInvent, To Present Further Positive Clinical PR Newswire

Nov 2, 2021

07:01AM EDT CASI Pharmaceuticals To Report Third Quarter 2021 Financial Results And Host PR Newswire

Oct 25, 2021

07:01AM EDT Financing Of $63 Million (RMB410 Million) For Acceleration Of CNCT19 Pivotal Trials And Commercialization PR Newswire

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Sep 20, 2021

07:01AM EDT CASI Pharmaceuticals, Inc. To Participate In Oppenheimer Fall Healthcare Life PR Newswire

Aug 23, 2021

09:58AM EDT 4 Penny Stocks Insiders Are Buying Benzinga

Aug 12, 2021

07:08AM EDT CASI Pharmaceuticals Q2 Net Loss $6.7 Mln Vs. Net Loss $8.5 Mln Last Year RTTNews

07:02AM EDT CASI Pharmaceuticals Announces Second Quarter 2021 Financial Results PR Newswire

Aug 10, 2021

07:01AM EDT CASI Pharmaceuticals To Report Second Quarter 2021 Financial Results And Host PR Newswire

Jul 28, 2021

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

Jul 27, 2021

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

Jul 9, 2021

07:36AM EDT The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO Benzinga

Jun 10, 2021

07:04AM EDT CASI Pharma Doses First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma RTTNews

07:02AM EDT CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma Benzinga

07:01AM EDT CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 PR Newswire

May 27, 2021

07:02AM EDT CASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare PR Newswire

May 21, 2021

12:43PM EDT Return On Capital Employed Overview: CASI Pharmaceuticals Benzinga

May 18, 2021

10:05AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021 Benzinga

07:42AM EDT BTIG Initiates Coverage On CASI Pharmaceuticals with Buy Rating, Announces Price Target of $4 Benzinga

May 14, 2021

06:41AM EDT HC Wainwright & Co. Maintains Buy on CASI Pharmaceuticals, Raises Price Target to $4 Benzinga

May 13, 2021

07:27AM EDT CASI Pharmaceuticals: Q1 Earnings Insights Benzinga

07:17AM EDT CASI Pharma Q1 Loss Per Share $0.11 Vs Loss $0.0 Last Year RTTNews

07:03AM EDT CASI Pharmaceuticals Q1 EPS $(0.11) Misses $(0.06) Estimate, Sales $5.74M Beat $5.05M Estimate Benzinga

07:01AM EDT CASI Pharmaceuticals Announces First Quarter 2021 Financial Results PR Newswire

04:15AM EDT Earnings Scheduled For May 13, 2021 Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

07:02AM EDT CASI Pharmaceuticals To Report First Quarter 2021 Financial Results And Host PR Newswire

May 3, 2021

09:16AM EDT This Day In Market History: New York Times Article Suggests Cancer Cure By Year 2000 Benzinga

Apr 26, 2021

10:06AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2021 Benzinga

07:20AM EDT Mizuho Initiates Coverage On CASI Pharmaceuticals with Buy Rating, Announces Price Target of $3.8 Benzinga

Apr 3, 2021

02:05PM EDT Last Week's Notable Insider Buys: PennyMac Financial, Republic Services And More Benzinga

Mar 30, 2021

07:13AM EDT CASI Pharma FY Net Loss $47.5 Mln Vs Loss $45.4 Min Last Year RTTNews

07:03AM EDT CASI Pharmaceuticals FY20 Product Sales %$5M, Up From $4.06M YoY Benzinga

07:01AM EDT CASI Pharmaceuticals Announces Full Year 2020 Financial Results PR Newswire

Mar 24, 2021

08:59AM EDT The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping Benzinga

08:34AM EDT CASI Pharma Announces Pricing Of Public Offering Of 15.85 Mln Shares At $2.05/Shr RTTNews

08:32AM EDT CASI Pharmaceuticals Prices ~15.85M Share Common Stock Offering At $2.05/Share Benzinga

08:31AM EDT CASI Pharmaceuticals Announces Pricing Of $32,500,000 Public Offering Of Common PR Newswire

Mar 23, 2021

04:02PM EDT CASI Pharmaceuticals Announces A Common Stock Offering Benzinga

04:01PM EDT CASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock PR Newswire

Mar 11, 2021

04:31PM EST CASI Pharmaceuticals To Host Business Update Call March 12, 2021 PR Newswire

Mar 8, 2021

10:17AM EST CASI Pharmaceuticals To Develop CB-5339 In Cancer Indications In China Benzinga

08:46AM EST Cleave Licenses First-in-Class VCP/P97 Inhibitor CB-5339 To CASI Pharma For China RTTNews

08:46AM EST Cleave Therapeutics Licenses First-in-Class VCP/P97 Inhibitor CB-5339 To CASI PR Newswire

08:27AM EST Cleave Therapeutics Say Licenses VCP/P97 Inhibitor CB-5339 To CASI Pharmaceuticals For Greater China Region; Co To Receive $5.5M Up Front, Up To $74M In Development, Commercial Milestone Payments Benzinga

Feb 16, 2021

07:19AM EST CASI Pharma Says Sees EVOMELA Unaudited Revenue Of About $4.8 Mln For Q4 RTTNews

07:09AM EST CASI Pharmaceuticals Sees Prelim. Q4 EVOMELA Sales ~$4.8M, Sees Prelim. FY20 EVOMELA Sales ~$15M Benzinga

07:02AM EST CASI Pharmaceuticals Announces Preliminary Fourth Quarter And Full-Year 2020 PR Newswire

Feb 12, 2021

03:04PM EST CASI Pharmaceuticals Shares See Volume; Federated Hermes Reports In 13G Filing A 5.6% Stake In Co Benzinga

Jan 28, 2021

07:19AM EST CASI Pharma Reports Its Partner, BioInvent, Presents Phase 1/2a Data Suggesting BI-1206 Restores Activity Of Rituximab In Relapsed Non-Hodgkin's Lymphoma Patients Benzinga

07:01AM EST Suggests BI-1206 Restores Activity Of Rituximab In Relapsed Non-Hodgkin's Lymphoma Patients PR Newswire

Jan 27, 2021

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

Jan 21, 2021

07:01AM EST CASI Pharmaceuticals Partner, BioInvent, To Host Key Opinion Leader Call On PR Newswire

Jan 20, 2021

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 8, 2021

07:01AM EST CASI Pharmaceuticals, Inc. To Present At H.C. Wainwright Bioconnect Conference PR Newswire

Dec 23, 2020

01:39PM EST CASI Pharmaceuticals shares were trading higher after the company announced CNCT19 received breakthrough therapy designation in China. Benzinga

07:03AM EST CASI Pharma Reports CNCT19 Receives Chine Breakthrough Therapy Designation Benzinga

07:02AM EST CASI Pharma: Chinese Center For Drug Evaluation Grants Breakthrough To Its Partner Juventas Cell Therapy For CNCT19 RTTNews

07:01AM EST CASI Pharmaceuticals Announces CNCT19 (CD19 CAR-T) Receives China Breakthrough PR Newswire

Dec 18, 2020

04:08PM EST CASI Pharmaceuticals Inc >CASI CFO Xu Buys 6,000 Shares @ Avg Price $2.57/Share Benzinga

Dec 16, 2020

07:05AM EST CASI Pharmaceuticals Announces Appointment Of Weihao Xu as Chief Financial Officer Benzinga

07:01AM EST CASI Pharmaceuticals Appoints Weihao Xu To The Position Of CFO RTTNews

07:01AM EST CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer PR Newswire

Nov 18, 2020

09:27PM EST CASI Pharma Announces Partner Juventas Completes $65 Mln Financing And Initiates Registration Study For CNCT19 RTTNews

09:01PM EST CASI Pharmaceuticals Announces Partner Juventas Completes $65 Million Financing PR Newswire

Nov 9, 2020

08:20AM EST CASI Pharmaceuticals: Q3 Earnings Insights Benzinga

07:32AM EST CASI Pharmaceuticals Q3 EPS $(0.14) Misses $(0.05) Estimate, Sales $4.24M Beat $3.44M Estimate Benzinga

07:01AM EST CASI Pharmaceuticals Announces Third Quarter 2020 Financial Results PR Newswire

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Nov 5, 2020

07:01AM EST CASI Pharmaceuticals To Report Third Quarter 2020 Financial Results And Host PR Newswire

Oct 27, 2020

07:17AM EDT BioInvent licenses Anti-FcRllB Antibody BI-1206 To CASI Pharmaceuticals For Greater China region Benzinga

07:01AM EDT BioInvent licenses anti-FcyRllB antibody BI-1206 to CASI Pharmaceuticals for PR Newswire

Oct 23, 2020

11:48AM EDT Oppenheimer Initiates Coverage On CASI Pharmaceuticals with Outperform Rating, Announces Price Target of $5 Benzinga

Oct 2, 2020

07:01AM EDT CASI Pharmaceuticals Announces Poster Presentation At The 2020 AABB Virtual PR Newswire

Sep 29, 2020

07:01AM EDT CASI Pharmaceuticals Announces Restructuring of Partnership with Juventas Cell PR Newswire

Sep 11, 2020

07:01AM EDT CASI Pharmaceuticals, Inc. to Participate in Two Upcoming September Conferences PR Newswire

Sep 2, 2020

04:26PM EDT CASI Pharmaceuticals Says On Aug. 27 Co. And Wuxi Jintou Huicun Investment Enterprise Entered Construction Project Contract; CASI-Wuxi Will Pay A Contract Price Of $10.923M Benzinga

Aug 10, 2020

07:29AM EDT CASI Pharmaceuticals: Q2 Earnings Insights Benzinga

07:19AM EDT CASI Pharma Q2 Loss Per Share $0.09 Vs Loss $0.16 Last Year RTTNews

07:11AM EDT CASI Pharmaceuticals Q2 EPS $(0.09) Misses $(0.08) Estimate, Sales $2.67M Miss $3.75M Estimate Benzinga

07:01AM EDT CASI Pharmaceuticals Announces Second Quarter 2020 Financial Results PR Newswire

04:10AM EDT Earnings Scheduled For August 10, 2020 Benzinga

Aug 3, 2020

07:02AM EDT CASI Pharmaceuticals To Report Second Quarter 2020 Financial Results And Host PR Newswire

Jul 22, 2020

09:12AM EDT CASI Pharma Prices 20M Shares At $1.90/Share Benzinga

09:12AM EDT CASI Pharma Prices Underwritten Public Offering Of 20 Mln Shares At $1.90/Shr RTTNews

09:06AM EDT CASI Pharmaceuticals Announces Pricing Of $38,000,000 Public Offering Of Common PR Newswire

Jul 21, 2020

04:11PM EDT CASI Pharma Announces Proposed Public Offering Of Common Stock RTTNews

04:01PM EDT CASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock PR Newswire